DaVita HealthCare (DVA) Q4 Earnings and Revenues Surpass Estimates

Core Viewpoint - DaVita HealthCare reported quarterly earnings of $3.4 per share, exceeding the Zacks Consensus Estimate of $3.24 per share, and showing a significant increase from $2.24 per share a year ago, indicating strong financial performance [1] Financial Performance - The company achieved revenues of $3.62 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.69% and up from $3.29 billion in the same quarter last year [2] - Over the last four quarters, DaVita has exceeded consensus EPS estimates three times and topped revenue estimates four times [2] Stock Performance - DaVita HealthCare shares have declined approximately 3.8% since the beginning of the year, contrasting with the S&P 500's gain of 1.4% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $2.47 on revenues of $3.32 billion, and for the current fiscal year, it is $12.89 on revenues of $13.9 billion [7] - The trend of earnings estimate revisions prior to the earnings release was mixed, which may influence future stock performance [6] Industry Context - The Medical - Outpatient and Home Healthcare industry, to which DaVita belongs, is currently ranked in the bottom 20% of over 250 Zacks industries, suggesting potential challenges ahead [8]